Slc35a2-cdg

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-06-29
Clinical Trial Update: AVTX-801 D-galactose Supplementation in SLC35A2-CDG [Phase 2]
A Phase 2 clinical trial (AVTX-801) using D-galactose supplementation for SLC35A2-CDG is not yet recruiting.